Long non coding RNA NRON inhibited breast cancer development through regulating miR-302b/SRSF2 axis

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
• The function of lncRNA NRON in breast cancer pathogenesis is not well understood.
• Previous studies implicated NRON in other cancer types, like hepatocellular carcinoma.

Purpose of the Study:

• To investigate the role and mechanism of lncRNA NRON in breast cancer.
• To determine if NRON acts as a tumor suppressor or oncogene in breast cancer.
• To identify downstream targets and pathways regulated by NRON in breast cancer.

Main Methods:

• Construction of NRON overexpression and knockdown vectors.
• Assessment of breast cancer cell proliferation and invasion.
• Dual-luciferase reporter assays to identify NRON binding targets.
• Rescue experiments to confirm the NRON-SRSF2 interaction.

Main Results:

• NRON expression was significantly downregulated in breast cancer tissues.
• NRON overexpression suppressed breast cancer cell proliferation and invasion.
• NRON knockdown promoted breast cancer development.
• NRON negatively regulated miR-302b, which targets SRSF2.

Conclusions:

• The lncRNA NRON/miR-302b/SRSF2 axis is a key player in breast cancer.
• NRON functions as a tumor suppressor in breast cancer.
• This study provides novel insights into the molecular mechanisms of breast cancer.